ENDRA Life Sciences Inc. (NDRA)
4.92
-0.29 (-5.57%)
At close: Jan 28, 2025, 2:53 PM
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 |
| Cash & Equivalents | 2.83M | 4.89M | 9.46M | 7.23M | 6.17M | 6.47M | 5.60M | 144.95K | 19.13K | 156.44K |
| Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Assets | 3.26M | 5.99K | 5.99K | n/a | -0.00 | 0.00 | -0.00 | n/a | n/a | -0.00 |
| Receivables | n/a | n/a | -1.35M | n/a | n/a | n/a | 6.85K | n/a | n/a | n/a |
| Inventory | n/a | 2.64M | 1.28M | 589.62K | 113.44K | 59.44K | 191.68K | 40.10K | 99.00K | 238.99K |
| Other Current Assets | 198.91K | 992.88K | 2.70M | 396.79K | 247.45K | 418.74K | 81.75K | 10.54K | 8.49K | 8.99K |
| Total Current Assets | 3.03M | 8.53M | 12.09M | 8.21M | 6.54M | 6.95M | 5.88M | 195.59K | 126.62K | 404.42K |
| Property-Plant & Equipment | 465.87K | 741.47K | 774.54K | 551.25K | 641.17K | 273.23K | 241.55K | 295.17K | 360.10K | 298.52K |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 3.72M | 747.46K | 780.53K | 551.25K | 641.17K | 273.23K | 241.55K | 295.17K | 360.10K | 298.52K |
| Total Assets | 6.75M | 9.27M | 12.87M | 8.76M | 7.18M | 7.22M | 6.12M | 490.76K | 486.72K | 702.93K |
| Account Payables | 360.40K | 613.96K | 791.05K | 402.91K | 1.28M | 631.47K | 780.26K | 227.74K | 80.94K | 11.50K |
| Deferred Revenue | n/a | n/a | n/a | n/a | n/a | -22.51 | n/a | 206.81K | n/a | n/a |
| Short-Term Debt | 202.34K | 180.71K | 264.66K | 152.96K | 430.45K | n/a | n/a | 949.98K | n/a | n/a |
| Other Current Liabilities | 340.35K | 909.05K | 488.06K | 430.79K | 363.90K | 343.11K | 67.95K | 206.81K | 155.48K | 86.10K |
| Total Current Liabilities | 903.10K | 1.70M | 1.54M | 986.66K | 2.07M | 974.58K | 848.21K | 1.38M | 236.42K | 97.60K |
| Long-Term Debt | 192.06K | 365.92K | 546.63K | 608.99K | 342.81K | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.00 | n/a |
| Total Long-Term Liabilities | 192.06K | 365.92K | 546.63K | 608.99K | 342.81K | n/a | n/a | n/a | 1.00 | n/a |
| Total Liabilities | 1.10M | 2.07M | 2.09M | 1.60M | 2.42M | 974.58K | 848.21K | 1.38M | 236.42K | 97.60K |
| Total Debt | 394.40K | 546.63K | 678.96K | 685.47K | 707.07K | 22.51 | n/a | 949.98K | n/a | n/a |
| Common Stock | 1.04K | 317.00 | 4.25K | 3.40K | 842.00 | 742.00 | 392.00 | 253.00 | 253.00 | 200.00 |
| Retained Earnings | -91.93M | -81.87M | -68.69M | -57.34M | -45.22M | -27.69M | -17.90M | -12.52M | -9.74M | -7.46M |
| Comprehensive Income | 5.23K | 6.07K | 13.86K | 10.79K | 43.53K | -405.95K | -337.63K | -276.15K | -208.09K | -188.67K |
| Shareholders Equity | 5.66M | 7.20M | 10.78M | 7.17M | 4.76M | 6.25M | 5.28M | -893.77K | 250.30K | 605.33K |
| Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |